Delivering On the Promise of Glioblastoma Immunotherapy
Time: 12:30 pm
day: Conference Day Two
Details:
- Local delivery in the brain eliminates the need to cross the BBB, opening new
GBM treatment opportunities - Combination therapy that can educate the immune system and generate
immune memory is required to obtain long-lasting anti-tumor responses - Sustained delivery of the therapy is required to bridge the innate and adaptive
immune responses to obtain immune memory
